The purpose of this study is to see whether low level laser therapy can help maintain normal hair growth on the scalp in people receiving chemotherapy, which is generally associated with hair loss.

Chemotherapy is a common treatment given to patients with breast cancer. Many chemotherapy drugs cause rapid hair loss. While hair loss is temporary, this side effect is a significant concern for patients. Low level laser therapy has been shown to help make hair grow. It is hoped that it may stop hair loss from occurring.

Participants will be receiving 20 to 30 minute laser sessions to their scalp twice a week beginning two weeks before treatment begins until one week past the last chemotherapy session. . Photographs will be taken during each study participant's initial visit, during treatment visits, and one month following the final chemotherapy treatment.

Inclusion Criteria:

• Participants must have breast cancer and must be starting chemotherapy with Adriamycin or a taxane-based therapy.
• Participants must be 18 years old or older
• Participants must be female
• Participant must agree to comply with therapeutic and follow-up schedule.
• Patient must signed informed consent form.

Exclusion Criteria:

• Participants cannot have sensitivity to the laser light.
• Participants cannot have used any topical or oral products to grow hair within 3 months of enrollment to this study.
• Participants cannot be pregnant, lactating or planning on pregnancy during therapeutic schedule.